AGN-190584 + Vehicle
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Presbyopia
Conditions
Presbyopia
Trial Timeline
May 14, 2021 → Dec 7, 2021
NCT ID
NCT04837482About AGN-190584 + Vehicle
AGN-190584 + Vehicle is a phase 3 stage product being developed by AbbVie for Presbyopia. The current trial status is completed. This product is registered under clinical trial identifier NCT04837482. Target conditions include Presbyopia.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04837482 | Phase 3 | Completed |
Competing Products
14 competing products in Presbyopia